Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Catalyst Pharmaceutical Partners Inc announces closing of public offering


Tuesday, 8 Apr 2014 10:30am EDT 

Catalyst Pharmaceutical Partners Inc:Closes public offering of shares of common stock.Company sold 13,023,750 shares of common stock in offering, including 1,698,750 shares that were issued upon exercise by underwriters of their overallotment option.Offering price was $2.21 per share, and net proceeds from sale of shares is expected to be $26.8 mln.Piper Jaffray & Co. acted as sole book-running manager for offering, Roth Capital Partners acted as co-lead manager, and H.C. Wainwright & Co., LLC acted as co-manager with respect to offering. 

Company Quote

3.2
0.08 +2.56%
29 Aug 2014